Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0262471 (
ENT
)
5,307
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Principles of a novel methodology for the combined assessment of the immune function in sickly children with pathological changes in the organs of the otorhinolaringological system are expounded. The new approach includes investigations into local cellular and humoral immunity, evaluation of functional relationships and correlations between its parameters, interpretation of these findings, and the use of the characteristics thus obtained in the development of concrete recommendations for immunotropic and/or anti-inflammatory therapy. This approach is illustrated by examples of variations in the number of
CD4
(+) and CD20(+) cells and interplay between them. These findings taken together with the data on the levels of serum IgG, IgA, IgM, and percentage of immunohistochemical preparations positive for these immunoglobulins indicate that the proposed method may prove useful for the development of new therapeutic modalities for the treatment of sickly children with
ENT
organ pathology following adenotomy and tonsilotomy.
...
PMID:[Novel methodological approaches to the evaluation of the immune status in sickly children with ENT organ pathology]. 1936 63
The objective of the present study was to estimate the prevalence of chronic pathology of
ENT
organs and mucous membrane of the oral cavity in the HIV-infected patients depending on the number of cells containing
CD4
markers in 1 mcl of blood plasma. It was shown that the prevalence of chronic pathology of
ENT
organs and oral mucosa in the HIV-infected patients depends on the number of cells carrying
CD4
markers in 1 mcl of blood plasma. This pathology was found in 64.6% of the patients at immunological stage I of infection with human immunodeficiency virus (over 500
CD4
per 1 mcl plasma), in 73.4% of the patients at stage II of HIV infection (200-499
CD4
/1 mcl), and in 90.7% of the patients at stage III of HIV infection (less than 200
CD4
/1 mcl). The frequency of individual nosological forms of
ENT
disease at different stages of infection with human immunodeficiency virus is discussed. Certain diseases pathognomonic for HIV-infected adult subjects were identified including adenoid vegetations, cheilitis, oral hairy leukoplakia, and oropharyngeal candidiasis. Combined chronic pathology of
ENT
organs as well as certain clinical features of the above diseases may suggest diagnosis of immunodeficiency and require the assessment for the HIV status.
...
PMID:[The prevalence of chronic pathology of ENT organs and oral mucosa in the HIV-infected patients depending on their immune status]. 2352 60
Basic knowledge concerning the human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) is useful for
ENT
physicians. Although HIV patients are usually stably asymptomatic nowadays due to modern therapy, HIV often manifests in ENT symptoms, such as neck lumps, sore throat, difficulty swallowing and dysgeusia. After infection, an initial increase in viral load can cause, among other symptoms, oral ulcers and pharyngitis. Once the immune system is compromised by the attack on
CD4
lymphocyte cells, HIV-related diseases can occur: oral mycoses (particularly candidosis) and viral infections (including warts), aphthous ulcers, gingivitis, salivary gland diseases and malignancies (e. g. intraoral Kaposi's sarcoma). Neck lymphadenopathy is frequent. Markers of disease severity are the clinical symptoms, viral load and
CD4
helper cell count. HIV treatment (antiretroviral therapy, ART) is a combination of at least three antiviral drugs.
...
PMID:[A practically orientated clinical HIV update for ENT physicians]. 2535 97